Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.52 |
| ▸ | BACE1 | P56817 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.45 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5428009 | 1.00 | BCHE (0.52) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL4591692 | 0.88 | FUCA1 (0.56) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL1239295 | 0.85 | ALDH1A1 (0.57) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL1241903 | 0.85 | ALDH1A1 (0.57) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL1239292 | 0.85 | ALDH1A1 (0.57) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL5157349 | 0.83 | FUCA1 (0.66) | BCHEACHEBACE1ALDH1A1SIGMAR1 | |
| SCHEMBL5157969 | 0.83 | FUCA1 (0.66) | BCHEACHEBACE1ALDH1A1SIGMAR1 | |
| SCHEMBL1927705 | 0.81 | ALDH1A1 (0.58) | BCHEACHEBACE1ALDH1A1KDM4E | |
| SCHEMBL18321438 | 0.80 | BCHE (0.56) | BCHEACHEBACE1ALDH1A1SIGMAR1 | |
| SCHEMBL18321436 | 0.80 | BCHE (0.56) | BCHEACHEBACE1ALDH1A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1943231-A1 | (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-07-16 | — | — | EP | disclosed |
| US-20070111981-A1 | New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds | ROTH GERALD J | 2007-05-17 | — | — | US | disclosed |
| WO-2007048802-A1 | (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111981-A1 | New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds | MCHR1, GPR119, MCHR2 | BCHE 2189/4885ACHE 3017/4885BACE1 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.